Institut AllergoSan, a leader in gut microbiome and probiotic research and formulation, has served European pharmacies and practitioners for over 25 years. In partnership with AllergoSan USA, their evidence-based formulations are now available in the U.S. market. The Omni-Biotic® probiotic line is uniquely aligned with the Company's commitment to the highest quality, research, and evidence standards. This equates to every human source probiotic strain being identified and analyzed in vitro to determine its particular mechanistic strengths. Every probiotic formulation is further designed and tested for synergistic performance through preclinical and controlled human trials. Each product also undergoes gastric resistance and metabolic activity analysis as well as extended real-time stability testing, to ensure every serving delivers at full potency. Provided in powder form for rapid migration and robust metabolic activity, Omni-Biotic formulations are hypoallergenic and individually packaged for protection, portability, and convenience.